<?xml version="1.0" ?>
<document id="ca866226d436ba4c39fe854f9cc568f08638868d">
  <chunk id="ca866226d436ba4c39fe854f9cc568f08638868d.c0" text="EBV-gp350 Confers B-Cell Tropism to Tailored Exosomes and Is a Neo-Antigen in Normal and Malignant B Cells- A New Option for the Treatment of B-CLL"/>
  <chunk id="ca866226d436ba4c39fe854f9cc568f08638868d.c1" text="gp350, the major envelope protein of Epstein-Barr-Virus, confers B-cell tropism to the virus by interacting with the B lineage marker CD21. Here we utilize gp350 to generate tailored exosomes with an identical tropism. These exosomes can be used for the targeted co-transfer of functional proteins to normal and malignant human B cells. We demonstrate here the cotransfer of functional CD154 protein on tailored gp350+ exosomes to malignant B blasts from patients with B chronic lymphocytic leukemia (B-CLL), rendering B blasts immunogenic to tumor-reactive autologous T cells. Intriguingly, engulfment of gp350+ exosomes by B-CLL cells and presentation of gp350-derived peptides also re-stimulated EBV-specific T cells and redirected the strong antiviral cellular immune response in patients to leukemic B cells. In essence, we show that gp350 alone confers B-cell tropism to exosomes and that these exosomes can be further engineered to simultaneously trigger virus-and tumor-specific immune responses. The simultaneous exploitation of gp350 as a tropism molecule for tailored exosomes and as a neo-antigen in malignant B cells provides a novel attractive strategy for immunotherapy of B-CLL and other B-cell malignancies.">
    <entity charOffset="26-33" id="ca866226d436ba4c39fe854f9cc568f08638868d.c1.e0" ontology_id="CHEBI_16541" text="protein" type="chemical"/>
    <entity charOffset="289-297" id="ca866226d436ba4c39fe854f9cc568f08638868d.c1.e1" ontology_id="CHEBI_36080" text="proteins" type="chemical"/>
    <entity charOffset="392-399" id="ca866226d436ba4c39fe854f9cc568f08638868d.c1.e2" ontology_id="CHEBI_16541" text="protein" type="chemical"/>
    <entity charOffset="471-499" id="ca866226d436ba4c39fe854f9cc568f08638868d.c1.e3" ontology_id="DOID_1040" text="chronic lymphocytic leukemia" type="disease"/>
    <entity charOffset="491-499" id="ca866226d436ba4c39fe854f9cc568f08638868d.c1.e4" ontology_id="DOID_1240" text="leukemia" type="disease"/>
    <entity charOffset="671-679" id="ca866226d436ba4c39fe854f9cc568f08638868d.c1.e5" ontology_id="CHEBI_16670" text="peptides" type="chemical"/>
    <entity charOffset="746-755" id="ca866226d436ba4c39fe854f9cc568f08638868d.c1.e6" ontology_id="CHEBI_22587" text="antiviral" type="chemical"/>
    <entity charOffset="1057-1065" id="ca866226d436ba4c39fe854f9cc568f08638868d.c1.e7" ontology_id="CHEBI_25367" text="molecule" type="chemical"/>
    <pair e1="ca866226d436ba4c39fe854f9cc568f08638868d.c1.e0" e2="ca866226d436ba4c39fe854f9cc568f08638868d.c1.e3" id="ca866226d436ba4c39fe854f9cc568f08638868d.c1.p0" relation="true"/>
    <pair e1="ca866226d436ba4c39fe854f9cc568f08638868d.c1.e0" e2="ca866226d436ba4c39fe854f9cc568f08638868d.c1.e4" id="ca866226d436ba4c39fe854f9cc568f08638868d.c1.p1" relation="true"/>
    <pair e1="ca866226d436ba4c39fe854f9cc568f08638868d.c1.e1" e2="ca866226d436ba4c39fe854f9cc568f08638868d.c1.e3" id="ca866226d436ba4c39fe854f9cc568f08638868d.c1.p2" relation="true"/>
    <pair e1="ca866226d436ba4c39fe854f9cc568f08638868d.c1.e1" e2="ca866226d436ba4c39fe854f9cc568f08638868d.c1.e4" id="ca866226d436ba4c39fe854f9cc568f08638868d.c1.p3" relation="true"/>
    <pair e1="ca866226d436ba4c39fe854f9cc568f08638868d.c1.e2" e2="ca866226d436ba4c39fe854f9cc568f08638868d.c1.e3" id="ca866226d436ba4c39fe854f9cc568f08638868d.c1.p4" relation="true"/>
    <pair e1="ca866226d436ba4c39fe854f9cc568f08638868d.c1.e2" e2="ca866226d436ba4c39fe854f9cc568f08638868d.c1.e4" id="ca866226d436ba4c39fe854f9cc568f08638868d.c1.p5" relation="true"/>
    <pair e1="ca866226d436ba4c39fe854f9cc568f08638868d.c1.e3" e2="ca866226d436ba4c39fe854f9cc568f08638868d.c1.e5" id="ca866226d436ba4c39fe854f9cc568f08638868d.c1.p6" relation="true"/>
    <pair e1="ca866226d436ba4c39fe854f9cc568f08638868d.c1.e3" e2="ca866226d436ba4c39fe854f9cc568f08638868d.c1.e6" id="ca866226d436ba4c39fe854f9cc568f08638868d.c1.p7" relation="true"/>
    <pair e1="ca866226d436ba4c39fe854f9cc568f08638868d.c1.e3" e2="ca866226d436ba4c39fe854f9cc568f08638868d.c1.e7" id="ca866226d436ba4c39fe854f9cc568f08638868d.c1.p8" relation="true"/>
    <pair e1="ca866226d436ba4c39fe854f9cc568f08638868d.c1.e4" e2="ca866226d436ba4c39fe854f9cc568f08638868d.c1.e5" id="ca866226d436ba4c39fe854f9cc568f08638868d.c1.p9" relation="true"/>
    <pair e1="ca866226d436ba4c39fe854f9cc568f08638868d.c1.e4" e2="ca866226d436ba4c39fe854f9cc568f08638868d.c1.e6" id="ca866226d436ba4c39fe854f9cc568f08638868d.c1.p10" relation="true"/>
    <pair e1="ca866226d436ba4c39fe854f9cc568f08638868d.c1.e4" e2="ca866226d436ba4c39fe854f9cc568f08638868d.c1.e7" id="ca866226d436ba4c39fe854f9cc568f08638868d.c1.p11" relation="true"/>
  </chunk>
</document>
